A*STAR stealth technology gets viruses past the immune system; Texas researcher gets $1.5M for pollen grain delivery system;

> A*STAR Institute of Bioengineering and Nanotechnology researchers have created a stealth technology that coats therapeutic viruses with peptide and DNA microfibers, allowing them to slip past the immune system and increase survival time in mice with cancer. Press release

> A Texas Tech University researcher has been given a 5-year, $1.5 million grant from the National Institutes of Health (NIH) to develop an oral vaccine delivery system based on pollen grains. Press release

> Protocells, silica and lipid nanoparticles show potential to target drugs to where they are needed. Article

> Startup Tangent Medical Technologies received FDA approval to sell NovaCath, its alternative to standard IV delivery systems. Article

> Silica-based delivery system could solve the riddle of oral peptide delivery. Abstract

> Pearl Therapeutics has completed a randomized, double-blind Phase IIb study of the long-acting muscarinic antagonist (LAMA), glycopyrrolate, for the treatment of COPD. Press release

> The European Medicines Agency has released draft guidelines on oral modified release products and transdermal patches. Press release | Article

> Israeli researchers create gold nanospheres that release rituximab in response to laser light. Paper (PDF)

> Nanodiamonds deliver doxorubicin. Article

And Finally… Purdue University researchers develop a drug delivery micropump powered by a tiny brewery! Article

Suggested Articles

Chiasma's new acromegaly pill Mycapssa, aiming to convert patients from injectables, turned out positive 48-week data from an extension study.

Medicated chewing gum is a prime drug delivery target, but it's tough to test. An experimental set of robot jaws could ease that burden.

J&J has new data that should convince regulators to clear its subcutaneous Darzalex in another indication—widening its edge over a Sanofi rival.